Wedbush Reiterates Outperform Rating, $4 PT on Novavox on New Avian Influenza Reports
April 05, 2013 at 12:33 PM EDT
In a report published Friday, Wedbush analyst Gregory R. Wade reiterated an Outperform rating and $4.00 price target on Novavox (NASDAQ: NVAX ). In the report, Wade noted, “From China, there have been recent reports of a lethal new avian influenza virus (H7N9) that has reportedly killed six people, and
